The Regulatory Affairs and Quality Team at Leap Therapeutics is responsible for ensuring compliance with regulatory requirements throughout the drug development process. This team manages submissions to regulatory agencies, oversees Good Clinical Practice (GCP) quality assurance, and coordinates drug safety and pharmacovigilance operations. Their efforts are crucial in maintaining the integrity of clinical trials and ensuring that the company's innovative cancer therapies meet the highest standards of safety and efficacy.